In addition, other agents targeting on the inhibition of the NLRP3 inflammasome were reported in animal depression models, although the specific mechanisms remained unclear (Cao et al., 2017; Liu and Liu, 2017). Here, NLRP3 is linked to depressive symptom measurement.